Source comparison
Hexarelin Safe Side Effects: Comparison of Administration Protocols
Daily (no cycling) 40% of initial response Daily spikes (28–32 ng/mL peak) Cumulative. Resting HR increases 5–8 bpm by week 3 High. Significant by day 14 Poor for extended studies beyond 2 weeks 5 days on / 2 days off 85% of initial response Intermittent spike
This comparison does not assign a generated winner or score.
- Daily (no cycling)
- 40% of initial response
- Daily spikes (28–32 ng/mL peak)
- Cumulative. Resting HR increases 5–8 bpm by week 3
- High. Significant by day 14
- Poor for extended studies beyond 2 weeks
- 5 days on / 2 days off
- 85% of initial response
- Intermittent spikes only on dosing days
- Moderate. No cumulative baseline shift
- Low. Minimal attenuation at 4 weeks
- Strong for 4–8 week protocols
- Alternate-day dosing
- 70% of initial response
- Reduced frequency (every 48 hours)
- Low. Cardiovascular markers return to baseline between doses
- Moderate. Some attenuation by week 6
- Suitable for metabolic studies with longer timelines
- Pulsed (2 weeks on / 2 weeks off)
- 90% of initial response post-washout
- Intermittent with full recovery periods
- Minimal. Complete cardiovascular reset during off-weeks
- Very low. Receptor sensitivity fully restored during washout
- Ideal for studies requiring sustained efficacy across 12+ weeks